Skip to main navigation
  • Contact Us
  • Global
    • International
    • Canada
    • France
    • Germany
    • Italy
    • Japan
    • Netherlands
    • Spain
Amicus Therapeutics
  • About Amicus
    • About Amicus
    • Chairman’s Welcome
    • Leadership
    • Belief Statement
    • Contact Us
    • Message from BIO
  • Patient Advocacy
    • Patient Advocacy
    • Disease Information
    • Rare Stories
    • Patient Advisory Boards
    • Corporate Giving
    • Resources
    • Expanded Access
  • Programs & Pipeline
    • Programs & Pipeline
    • Our Pipeline
    • Fabry Disease
    • Pompe Disease
    • Batten Disease
    • Additional Preclinical Programs
    • Clinical Trials
    • Platform Technologies
    • Journal Articles
    • Publications & Posters
  • Product
    • Product
    • Galafold®
    • Amicus Assist™
  • Responsibility
    • Responsibility
    • Ethics & Compliance
    • Global Medical Affairs
    • Corporate Giving
    • Healing Beyond Disease
    • ESG Report
  • Investors & Media
    • Investors & Media
    • Investor Relations
    • Senior Management Team
    • Board of Directors
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Annual Reports and Proxies
    • SEC Filings
    • Stock Performance
    • Investor FAQs
    • Contact Us
    • Sign Up for Email Alerts
    • Featured Coverage
    • Electronic Press Kit
  • Careers
    • Careers
    • Overview
    • Search

Investors

Investor Calendar

ePosters at the 26th International Congress of the World Muscle Society

Sep 20 - Sep 24, 2021

Supporting Materials

Poster: Cipaglucosidase alfa/miglustat versus alglucosidase alfa/placebo in late-onset Pompe disease: PROPEL study subgroup analyses 302.3 KB
Poster: Living with late-onset Pompe disease in the UK: interim results characterising the patient journey and burden on physical, emotional and social quality of life 456.2 KB
  • About Amicus
    • Chairman’s Welcome
    • Leadership
    • Belief Statement
    • Contact Us
    • Message from BIO
  • Patient Advocacy
    • Disease Information
    • Rare Stories
    • Patient Advisory Boards
    • Corporate Giving
    • Resources
    • Expanded Access
  • Programs & Pipeline
    • Pipeline
    • Our Programs
    • Clinical Trials
    • Platform Technologies
    • Publications & Posters
    • Journal Articles
  • Product
    • Overview
    • Amicus Assist™
  • Responsibility
    • Ethics & Compliance
    • Global Medical Affairs
    • Corporate Giving
    • Healing Beyond Disease
    • ESG Report
  • Investors & Media
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Annual Reports & Proxies
    • SEC Filings
    • Stock Performance
    • Investor FAQs
    • Featured Coverage
  • Careers
    • Overview
    • Search
  • Social Media
    • Twitter
    • YouTube
    • LinkedIn
Copyright © 2023 Amicus Therapeutics. All rights reserved. NP-AT-ALL-00011119
  • Cookies Statement
  • Terms of Use
  • Privacy Notice
  • Privacy Shield Policy

The site you are about to enter is intended for US healthcare professionals.

Please confirm you are a US healthcare professional.

I am a US healthcare professional I am not a US healthcare professional